We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drug leakage from the edges of its transdermal patches has prompted Janssen Pharmaceuticals to issue a Class I recall on its Duragesic (fentanyl transdermal system) patches, the firm reported Feb. 17.